COMIRNATY OMICRON XBB.1.5
Google image searchProduct monograph
Active ingredient
raxtozinameran, 3 MCG/0.2 ML
DIN: 02541866
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Description: 2.25 ML MULTIDOSE VIAL
Schedule: Prescription
Company: BIONTECH MANUFACTURING GMBH
Date: 24-OCT-2023
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BN — Covid-19 vaccines (ATC, ATC/DDD)
- J07BN01 — COVID-19, RNA-BASED VACCINE (ATC/DDD)
